finanzen.net
23.03.2019 00:15
Bewerten
(0)

$17.3 Bn Stem Cell Banking Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

DRUCKEN

DUBLIN, March 22, 2019 /PRNewswire/ -- The "Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global stem cell banking market was worth US$ 8.1 Billion in 2018

Stem cell banking is one of the most promising as well as the fastest growing segment of the next-generation stem cell therapy. It is the process of extracting, freezing and storing stem cells for potential future use. Some of the sources through which stem cells are obtained include embryo, umbilical cord, cord blood, placenta and bone marrow.

These cells are used for treating a number of different diseases including diabetes, thalassemia, leukemia, sickle cell anemia and cardiac diseases. Moreover, they are also employed for generating platelets, red blood cells and white blood cells. The potential of stem cells to regenerate has led to their applications in tissue engineering, gene therapy and regenerative medicines.

Looking forward, we expect the global stem cell banking market to reach a value of US$ 17.3 Billion by 2024, exhibiting a CAGR of 13.5% during 2019-2024.

Global Stem Cell Banking Market Drivers:

While the average human life expectancy has increased owing to the advancements in medical science, human aging is still associated with several diseases. Thus, the elevating count of geriatric population will drive the demand for stem cell therapy in the coming years.

Regulatory authorities as well as non-governmental organizations (NGO), across both developed and emerging regions, are taking initiatives for instilling awareness amongst consumers about the therapeutic potentials of stem cells, thereby influencing the stem cell banking market growth.

Increasing fertility rates has led to a rise in the number of children across the globe. This offers lucrative opportunities for preserving the umbilical cord of infants which contains hematopoietic (blood) stem cells.

Some of the other factors which are catalyzing the growth of the market include escalating disposable incomes, increasing approval of clinical trials in stem cell research, growing prevalence of chronic diseases and technological advancements.

Product Type Insights:

On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.

Service Type Insights:

Based on service types, the market has been segmented as sample preservation and storage; sample analysis; sample processing; and sample collection and transportation.

Bank Type Insights:

Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.

Utilization Insights:

Based on the utilization, the market has been segregated as used and unused.

Application Insights:

On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.

Regional Insights:

On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.

Competitive Landscape:

The market is fragmented in nature with the presence various international as well as regional players. Some of the leading players operating in the market are:


  • CBR Systems Inc.
  • China Cord Blood Corporation
  • Cordlife
  • Cordvida
  • Cryo-Cell International, Inc.
  • Cryo-Save AG (A Group of Esperite)
  • Cryoviva India
  • Lifecell
  • Smart Cells International Ltd
  • Viacord

Key Questions Answered in This Report:

  • How has the global stem cell banking market performed so far and how will it perform in the coming years?
  • What are the key regions in the global stem cell banking market?
  • What is the breakup of the global stem cell banking market on the basis of product type?
  • What is the breakup of the global stem cell banking market on the basis of service type?
  • What is the breakup of the global stem cell banking market on the basis of bank type?
  • What is the breakup of the global stem cell banking market on the basis of utilization?
  • What is the breakup of the global stem cell banking market on the basis of application?
  • What are the various stages in the value chain of the global stem cell banking market?
  • What are the key driving factors and challenges in the global stem cell banking market?
  • What is the structure of the global stem cell banking market and who are the key players?
  • What is the degree of competition in the global stem cell banking market?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Properties
4.3 Key Industry Trends

5 Global Stem Cell Banking Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product Type
5.4 Market Breakup by Service Type
5.5 Market Breakup by Bank Type
5.6 Market Breakup by Utilization
5.7 Market Breakup by Application
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Product Type
6.1 Adult Stem Cells
6.2 Human Embryonic Cells
6.3 IPS Cells

7 Market Breakup by Service Type
7.1 Sample Preservation and Storage
7.2 Sample Analysis
7.3 Sample Processing
7.4 Sample Collection and Transportation

8 Market Breakup by Bank Type
8.1 Private
8.2 Public

9 Market Breakup by Utilization
9.1 Used
9.2 Unused

10 Market Breakup by Application
10.1 Personalized Banking Applications
10.2 Research Applications
10.3 Clinical Applications

11 Market Breakup by Region

12 Global Stem Cell Banking Industry: SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Global Stem Cell Banking Industry: Value Chain Analysis

14 Global Stem Cell Banking Industry: Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Global Stem Cell Banking Industry: Price Analysis

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 CBR Systems Inc.
16.3.2 China Cord Blood Corporation
16.3.3 Cordlife
16.3.4 Cordvida
16.3.5 Cryo-Cell
16.3.6 Cryo-Save AG (A Group of Esperite)
16.3.7 Cryoviva India
16.3.8 Lifecell
16.3.9 Smart Cells International Ltd
16.3.10 Viacord

For more information about this report visit https://www.researchandmarkets.com/research/jb9sz4/17_3_bn_stem?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html

SOURCE Research and Markets

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX schließt höher -- US-Börsen schwächer -- Softbank steigt bei Wirecard ein -- Deutsche Bank spricht wohl mit UBS über Fusion der Vermögensverwaltung -- Boeing, Snap, eBay, SAP im Fokus

Exxon investiert über eine Milliarde Dollar in Ausbau britischer Raffinerie. Eni verfehlt mit operativem Gewinn die Markterwartung. Bieterwettkampf um Anadarko - Occidental bietet 57 Milliarden Dollar. Five-Eye-Staaten schließen Huawei von Kern-Netzwerken aus. AT&T wächst nur dank Time-Warner-Zukauf. Biogen wächst deutlich.

Die 5 beliebtesten Top-Rankings

Die beliebtesten Arbeitgeber in Deutschland
Hier gibt es die beliebtesten Jobs
Die zehn größten Kapitalvernichter
Hier wurde am meisten Anlegergeld verbrannt
DIe innovativsten Unternehmen
Diese Unternehmen sind am fortschrittlichsten
Das hat sich geändert
Diese Aktien hat George Soros im Depot
Diese Aktien hat Warren Buffett im Depot
Einige Änderungen unter den Top-Positionen
mehr Top Rankings

Umfrage

Der Bitcoin konnte wieder über die Marke von 5.500 Dollar klettern. Wo sehen Sie den Kurs der Kryptowährung Ende 2019?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
SAP SE716460
Daimler AG710000
Amazon906866
Deutsche Bank AG514000
CommerzbankCBK100
BayerBAY001
Apple Inc.865985
BASFBASF11
TeslaA1CX3T
E.ON SEENAG99
Allianz840400
Aurora Cannabis IncA12GS7
Volkswagen (VW) AG Vz.766403
Deutsche Telekom AG555750